See If You Prequalify for a Cancer Study

Making Clinical Research Studies Easier to Find for Cancer Patients

This screener is powered by Massive Bio. Massive Bio helps cancer patients find clinical research studies for investigational treatments.

Here’s how they can support you to make it simpler:

  • Beginning with a simple questionnaire designed to understand your current condition, they will quickly determine if there are potential studies suitable for you.
  • Next, a Patient Relations Coordinator will reach out to discuss your options if you agree to be contacted. You can ask them any questions you may have about the process.
  • Massive Bio can collect your medical records on your behalf to find studies that match your profile. They will use advanced technology to match you with all possible cancer research studies. Their database is continuously updated to ensure you have access to all the latest studies.
  • You will receive a personalized report of all matching studies explaining each option and a specially trained nurse will then discuss the results with you to help you make informed decisions.
  • If you do not prequalify for a study now, Massive Bio will continue to check for new opportunities as your condition changes in the future.
  • If you prequalify, Massive Bio helps manage everything related to your study, from logistics to financial concerns. They will assist with scheduling your consultations and screening appointments with the study team, arrange your travel, and work with organizations like the American Cancer Society to find you lodging if needed, making your experience as smooth as possible.
  • Throughout the process, Massive Bio’s team will stay in touch with you to ensure you feel supported and informed. If any issues arise, they will be ready to help you explore other study options.

Massive Bio’s patient-centered approach is designed to make finding and participating in clinical research studies as easy and supportive as possible, ensuring you have access to suitable and available research studies.

Answer the questions below or call +1-844-627-7246 to see if you prequalify.
Massive Bio’s patient-centered approach is designed to make finding and participating in clinical research studies as easy and supportive as possible, ensuring you have access to the best treatment options available.

Learn more about how to enroll by contacting Massive Bio. You can call +1-844-627-7246 or click below to start the process.
Please note that by clicking “Continue,” you will be redirected to the Massive Bio website where you will be pre-screened for cancer clinical research studies. The privacy policy and terms of use on massivebio.com may be different from this website’s privacy policy and terms of use. Please refer to the privacy policy and terms of use of massivebio.com as we cannot control or be responsible for their policies, terms of use, or legal/privacy/regulatory compliance.
Many patients with metastatic CRC, GEA, or NSCLC with c-MET overexpression are seeking additional treatment options. Researchers are dedicated to opening up new possibilities through clinical research. Join them on this expedition and explore the AndroMETa Studies.
See If You’re Eligible
Colorectal cancer (CRC), gastroesophageal adenocarcinoma (collectively referred to here as GEA, which includes gastric, gastroesophageal junction, and esophageal adenocarcinomas), and non-small cell lung cancer (NSCLC) are all types of adenocarcinomas. An adenocarcinoma is a type of cancer that starts in the glands that line your organs.

CRC

CRC starts in the colon or rectum.

GEA

GEA can start in the stomach, the esophagus, or where the two organs meet—the junction.

NSCLC

NSCLC starts in the lung's tissue